ABEL: Type I Error [RSABE / ABEL]

posted by ElMaestro  – Denmark, 2020-09-29 12:41 (1328 d 21:35 ago) – Posting: # 21949
Views: 1,889

❝ … (don’t ask for the country):

… in case of a value of 30% < CVRR <45%, it is recommended to check the control of the patient's risk type I error at the level of 5%. If an alpha adjustment is necessary, it is recommended that a BE estimate for the new CI of the T/R ratio be submitted to meet the extended bounds.


That subjunction is correct but not part of the everyday linguistic toolbox of those who do not speak a lot of English. My guess is MHRA or the Irish Medicines Board or it comes from someone who spent a lot of time taking English language classes :-)

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,033 posts in 4,835 threads, 1,643 registered users;
32 visitors (1 registered, 31 guests [including 8 identified bots]).
Forum time: 10:16 CEST (Europe/Vienna)

Competence, like truth, beauty and contact lenses,
is in the eye of the beholder.    Laurence J. Peter

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5